REGISTERED
on 12 May 2020
Last Applicant/ Owned by
#A-815, 142-10,
KR
Serial Number
79264508 filed on 19th Jun 2019
Registration Number
6050283 registered on 12th May 2020
Filing Basis
No Filing Basis
Disclaimer
NO DATA
ABTIS
Pharmaceutical agents affecting metabolism; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulm Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical agents affecting metabolism; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biotechnological preparations for medical purposes, namely, for the treatment of oncological, metabolic and ophthalmic diseases and disorders; drugs for medical purposes, namely, for treating cancer; drugs for medical purposes, namely, for treating diabetes; drugs for medical purposes, namely, for treating ocular disease; antibodies for medical purposes, namely, for the treatment of oncological, metabolic and ophthalmic diseases and disorders; pharmaceutical compositions for the treatment of oncological, metabolic and ophthalmic diseases and disorders; medicines for human purposes for the treatment of oncological, metabolic and ophthalmic diseases and disorders; nutraceuticals for therapeutic purposes for the treatment of cancer; nutraceuticals for therapeutic purposes for the treatment of diabetes; therapeutic drugs and agents, namely, antibody drug conjugate comprising antibody and chemical compound attached for the treatment of oncological, metabolic and ophthalmic diseases and disorders; anti-cancer preparations
Class [042]
Computer & Software Services & Scientific Services
Research and development of vaccines and medicines; biotechnology research; biological research; crude medicines research; scientific research for medical purposes in the field of cancerous diseases; research on the subject of pharmaceuticals; medical research; clinical research in the field of oncology, metabolic disease and ophthalmology
Mark Details
Serial Number
No 79264508
Mark Type
No Service Mark
Attorney Docket Number
No I2420.82447U
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 28th Jan 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| 11th Oct 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 17th Sep 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| 17th Sep 2020 | FINAL DISPOSITION PROCESSED |
| 12th Aug 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 12th May 2020 | REGISTERED-PRINCIPAL REGISTER |
| 25th Feb 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 25th Feb 2020 | PUBLISHED FOR OPPOSITION |
| 22nd Feb 2020 | NOTIFICATION PROCESSED BY IB |
| 05th Feb 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |